Browse the full Event Guide to discover:

25+ expert speakers

including potency assay scientists and directors from Sarepta Therapeutics, Ultragenyx, Spark Therapeutics & Vertex Pharmaceuticals

6+ hours of dedicated networking time

including speed networking and poster sessions, to strengthen and forge long-term, mutually beneficial relationships

4 deep-dive pre-conference workshops

designed to stimulate conversation, discussion, and debate across topics including the new FDA guidance, the potency matrix & parallel line analysis

2 days of main agenda content

including sessions on phase-appropriate assay development, cell-based assay optimization and advancing CQA assessment

image (39)

Having issues downloading the brochure? Let us know and we'll email it to you instead.

Companies on the Program

48789 - previously attending companies (1)